Risk prediction of complex diseases from family history and known susceptibility loci, with applications for cancer screening - PubMed (original) (raw)
Risk prediction of complex diseases from family history and known susceptibility loci, with applications for cancer screening
Hon-Cheong So et al. Am J Hum Genet. 2011.
Abstract
Risk prediction based on genomic profiles has raised a lot of attention recently. However, family history is usually ignored in genetic risk prediction. In this study we proposed a statistical framework for risk prediction given an individual's genotype profile and family history. Genotype information about the relatives can also be incorporated. We allow risk prediction given the current age and follow-up period and consider competing risks of mortality. The framework allows easy extension to any family size and structure. In addition, the predicted risk at any percentile and the risk distribution graphs can be computed analytically. We applied the method to risk prediction for breast and prostate cancers by using known susceptibility loci from genome-wide association studies. For breast cancer, in the population the 10-year risk at age 50 ranged from 1.1% at the 5th percentile to 4.7% at the 95th percentile. If we consider the average 10-year risk at age 50 (2.39%) as the threshold for screening, the screening age ranged from 62 at the 20th percentile to 38 at the 95th percentile (and some never reach the threshold). For women with one affected first-degree relative, the 10-year risks ranged from 2.6% (at the 5th percentile) to 8.1% (at the 95th percentile). For prostate cancer, the corresponding 10-year risks at age 60 varied from 1.8% to 14.9% in the population and from 4.2% to 23.2% in those with an affected first-degree relative. We suggest that for some diseases genetic testing that incorporates family history can stratify people into diverse risk categories and might be useful in targeted prevention and screening.
Copyright © 2011 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.
Figures
Figure 1
Plots of Predicted Risks of Breast Cancer in the General Population and in Individuals with a Family History of Disease and with One Affected First-Degree Relative Top: The probability density functions of predicted risks. Middle: The predictiveness curve (predicted risk plotted against the risk percentile). Bottom: the cumulative density functions of predicted risks. The horizontal line in the middle graph represents the average lifetime risk in the whole population. People with an affected first-degree relative are denoted by “Fam Hx +ve.”
Figure 2
Ten-Year Risk of Breast Cancer at Different Risk Percentiles for the General Female Population The horizontal line represents the average 10-year risk of breast cancer for a 50-year-old woman.
Figure 3
Ten-Year Risk of Breast Cancer at Different Risk Percentiles for Women with One Affected First-Degree Relative The horizontal line represents the average 10-year risk of breast cancer for a 50-year-old woman.
Similar articles
- Common genetic variants in prostate cancer risk prediction--results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3).
Lindström S, Schumacher FR, Cox D, Travis RC, Albanes D, Allen NE, Andriole G, Berndt SI, Boeing H, Bueno-de-Mesquita HB, Crawford ED, Diver WR, Gaziano JM, Giles GG, Giovannucci E, Gonzalez CA, Henderson B, Hunter DJ, Johansson M, Kolonel LN, Ma J, Le Marchand L, Pala V, Stampfer M, Stram DO, Thun MJ, Tjonneland A, Trichopoulos D, Virtamo J, Weinstein SJ, Willett WC, Yeager M, Hayes RB, Severi G, Haiman CA, Chanock SJ, Kraft P. Lindström S, et al. Cancer Epidemiol Biomarkers Prev. 2012 Mar;21(3):437-44. doi: 10.1158/1055-9965.EPI-11-1038. Epub 2012 Jan 11. Cancer Epidemiol Biomarkers Prev. 2012. PMID: 22237985 Free PMC article. - First-degree family history of breast cancer is associated with prostate cancer risk: a systematic review and meta-analysis.
Ren ZJ, Cao DH, Zhang Q, Ren PW, Liu LR, Wei Q, Wei WR, Dong Q. Ren ZJ, et al. BMC Cancer. 2019 Sep 2;19(1):871. doi: 10.1186/s12885-019-6055-9. BMC Cancer. 2019. PMID: 31477094 Free PMC article. - Association between family history of cancer and breast cancer defined by estrogen and progesterone receptor status.
Tutera AM, Sellers TA, Potter JD, Drinkard CR, Wiesner GL, Folsom AR. Tutera AM, et al. Genet Epidemiol. 1996;13(2):207-21. doi: 10.1002/(SICI)1098-2272(1996)13:2<207::AID-GEPI6>3.0.CO;2-4. Genet Epidemiol. 1996. PMID: 8722747 Clinical Trial. - Incorporating genomics into breast and prostate cancer screening: assessing the implications.
Chowdhury S, Dent T, Pashayan N, Hall A, Lyratzopoulos G, Hallowell N, Hall P, Pharoah P, Burton H. Chowdhury S, et al. Genet Med. 2013 Jun;15(6):423-32. doi: 10.1038/gim.2012.167. Epub 2013 Feb 14. Genet Med. 2013. PMID: 23412607 Free PMC article. Review. - Polygenic Risk Scores in Prostate Cancer Risk Assessment and Screening.
Byrne L, Toland AE. Byrne L, et al. Urol Clin North Am. 2021 Aug;48(3):387-399. doi: 10.1016/j.ucl.2021.03.007. Epub 2021 Jun 10. Urol Clin North Am. 2021. PMID: 34210493 Review.
Cited by
- Exploring the role of underrepresented populations in polygenic risk scores for neurodegenerative disease risk prediction.
Step K, Ndong Sima CAA, Mata I, Bardien S. Step K, et al. Front Neurosci. 2024 May 27;18:1380860. doi: 10.3389/fnins.2024.1380860. eCollection 2024. Front Neurosci. 2024. PMID: 38859922 Free PMC article. No abstract available. - How group structure impacts the numbers at risk for coronary artery disease: polygenic risk scores and nongenetic risk factors in the UK Biobank cohort.
Zhao J, O'Hagan A, Salter-Townshend M. Zhao J, et al. Genetics. 2024 Jul 8;227(3):iyae086. doi: 10.1093/genetics/iyae086. Genetics. 2024. PMID: 38781512 Free PMC article. - Bayesian linear mixed model with multiple random effects for family-based genetic studies.
Hai Y, Zhao W, Meng Q, Liu L, Wen Y. Hai Y, et al. Front Genet. 2023 Oct 19;14:1267704. doi: 10.3389/fgene.2023.1267704. eCollection 2023. Front Genet. 2023. PMID: 37928242 Free PMC article. - Polygenic risk scores: the future of cancer risk prediction, screening, and precision prevention.
Wang Y, Zhu M, Ma H, Shen H. Wang Y, et al. Med Rev (2021). 2022 Feb 14;1(2):129-149. doi: 10.1515/mr-2021-0025. eCollection 2021 Dec. Med Rev (2021). 2022. PMID: 37724297 Free PMC article. Review. - mtPGS: Leverage multiple correlated traits for accurate polygenic score construction.
Xu C, Ganesh SK, Zhou X. Xu C, et al. Am J Hum Genet. 2023 Oct 5;110(10):1673-1689. doi: 10.1016/j.ajhg.2023.08.016. Epub 2023 Sep 15. Am J Hum Genet. 2023. PMID: 37716346 Free PMC article.
References
- Falconer D. The inheritance of liability to certain diseases, estimated from the incidence among relatives. Ann. Hum. Genet. 1965;29:51–76.
- Curnow R.N. The multifactorial model for the inheritance of liability to disease and its implications for relatives at risk. Biometrics. 1972;28:931–946. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical